Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Easing cellular traffic jams in Huntington’s disease may save brain cells

Easing cellular traffic jams in Huntington’s disease may save brain cells

Researcher develops new language intervention to help treat patients with rare form of dementia

Researcher develops new language intervention to help treat patients with rare form of dementia

Gene mutation may accelerate loss of memory and thinking skills in people with Alzheimer's risk

Gene mutation may accelerate loss of memory and thinking skills in people with Alzheimer's risk

Walking intervention may reestablish protective neuronal connections in older adults with MCI

Walking intervention may reestablish protective neuronal connections in older adults with MCI

Detailed images reveal how regulatory proteins affect function of brain receptors

Detailed images reveal how regulatory proteins affect function of brain receptors

Positive social support from adult children linked to reduced dementia risk

Positive social support from adult children linked to reduced dementia risk

Powerful pain medicine may help reduce vision damage of glaucoma

Powerful pain medicine may help reduce vision damage of glaucoma

Do brain training apps really work?

Do brain training apps really work?

Scientists aim to build computer model of complex memory formation

Scientists aim to build computer model of complex memory formation

Antidepressant improves drug delivery across the blood-brain barrier, rat study shows

Antidepressant improves drug delivery across the blood-brain barrier, rat study shows

Improvements to animal testing protocols could yield more useful clinical results

Improvements to animal testing protocols could yield more useful clinical results

Study provides preliminary evidence that Parkinson's disease may start in the gut

Study provides preliminary evidence that Parkinson's disease may start in the gut

Experts aim to develop noninvasive technology that accelerates learning

Experts aim to develop noninvasive technology that accelerates learning

New technique dramatically accelerates search for new cancer treatments

New technique dramatically accelerates search for new cancer treatments

Researchers discover genes linked to resilience against brain pathologies

Researchers discover genes linked to resilience against brain pathologies

Brain’s ability to rewire after injury can lead to long-term strains

Brain’s ability to rewire after injury can lead to long-term strains

Person's brain age could help identify risk of functional decline and mortality

Person's brain age could help identify risk of functional decline and mortality

Researchers identify new rare genetic variants linked to extreme longevity

Researchers identify new rare genetic variants linked to extreme longevity

Neurobiologists use skin stem cells to generate new microglia

Neurobiologists use skin stem cells to generate new microglia

Low levels of NPTX2 protein in the brain may lead to learning and memory loss in Alzheimer's disease

Low levels of NPTX2 protein in the brain may lead to learning and memory loss in Alzheimer's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.